Skip links

Product pipeline

PRODUCT

INDICATION

RESEARCH

PRECLINICAL

PHASE I

PHASE II

PHASE III

ATL1103

Acromegaly

ATL1102

Multiple Sclerosis

ATL1102

DMD

What we're working on.

ATL1102

DMD is caused by a mutation in the muscle dystrophin gene leading to severe progressive muscle loss and premature death.

ATL1102

A disease in which the immune system eats away at the protective covering of nerves.

ATL1103

A disorder in adults in which the pituitary gland produces too much growth hormone.

Other indications

Limb-Girdle Muscular Dystrophy

A diseases that cause weakness and wasting of the muscles in the arms and legs.

Long Covid

A variety of new, returning or ongoing symptoms that people experience more than four weeks after getting COVID-19.

The people driving Antisense.

Our Antisense directors are committed staff members and are ready to help.